Eczema is a common skin condition, but there are many types of eczema out there. Learn how to identify your rash with these ...

Essentially two serums in one, the INNBEAUTY Project Calm The Red Down Dual Chamber Serum eases redness both immediately and ...

Effective management of atopic dermatitis (AD) has been one of the top priorities for physicians over the years, as quality of life in these patients is compromised due to the disruptive symptoms that ...

The US FDA has approved Vtama 1% cream for the topical treatment of atopic dermatitis in adult and pediatric patients aged 2 ...

For some people, keeping up with eczema treatments can be difficult, but resources are available to help find relief from the ...

Netherlands: A recent study demonstrated that tralokinumab is an effective treatment for moderate-to-severe atopic dermatitis ...

Self-guided cognitive behavioral therapy (CBT) proved noninferior to clinician-guided CBT for reducing symptom severity in ...

JAK inhibitors approved for atopic dermatitis/eczema include Opzelura (Ruxolitinib), or Rinvoq (Upadacitinib). Vtama cream (tapinarof) is a once-daily steroid-free treatment approved to treat ...

The US FDA has approved Nemluvio (nemolizumab) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older.

MY-004 is under clinical development by Createrna Science and Technology and currently in Phase II for Atopic Dermatitis (Atopic Eczema).

A brief self-guided online Cognitive Behavioral Therapy (CBT) intervention was noninferior to comprehensive clinician-guided ...

Castle today provided an update on its test currently in development for use in patients diagnosed with moderate-to-severe atopic dermatitis.